Company / Current Liabilities
ANI Pharmaceuticals, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$278.1M
FY2025
5-year range
$87.5M / $278.1M
FY2021-FY2025
Trend
+43.0%
vs FY2024
Sector context
#50 of 213
Health Care
What the data says
ANI Pharmaceuticals, Inc.'s current liabilities of $278M is higher than 77% of companies in the Health Care sector (FY2025). Current Liabilities has increased for 6 consecutive years, from $62M in FY2019 to $278M in FY2025.
Based on SEC 10-K filings.
$278M in FY2025 with a 5-year CAGR of +28.8%. Top quartile in the Health Care sector.
Increased from $145M to $278M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +40.9%
- 5-Year CAGR
- +28.8%
- 10-Year CAGR
- -
Sector benchmark
-82.5% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s current liabilities has grown for 6 consecutive years.
- 5-year CAGR of +28.8%, indicating consistent growth.
- In FY2025, current liabilities increased 43.0% year-over-year.
- Ranks #50 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $278.1M | +43.0% |
| FY2024 | $194.5M | +33.7% |
| FY2023 | $145.5M | +46.3% |
| FY2022 | $99.4M | +13.6% |
| FY2021 | $87.5M | +11.4% |
| FY2020 | $78.6M | +27.4% |
| FY2019 | $61.7M | -62.7% |
| FY2018 | $165.5M | +322.0% |
| FY2017 | $39.2M | +22.8% |
| FY2016 | $31.9M | +171.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026